高级检索
    余涵知, 吴荻, 蒋杰. Selpercatinib——RET融合阳性非小细胞肺癌的曙光[J]. 循证医学, 2020, 20(5): 264-267. DOI: 10.12019/j.issn.1671-5144.2020.05.003
    引用本文: 余涵知, 吴荻, 蒋杰. Selpercatinib——RET融合阳性非小细胞肺癌的曙光[J]. 循证医学, 2020, 20(5): 264-267. DOI: 10.12019/j.issn.1671-5144.2020.05.003
    shu
    YU Han-zhi, WU Di, JIANG Jie. Selpercatinib: The Dawn of RET Fusion Positive in Non-Small-Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2020, 20(5): 264-267. DOI: 10.12019/j.issn.1671-5144.2020.05.003
    Citation: YU Han-zhi, WU Di, JIANG Jie. Selpercatinib: The Dawn of RET Fusion Positive in Non-Small-Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2020, 20(5): 264-267. DOI: 10.12019/j.issn.1671-5144.2020.05.003
    shu

    Selpercatinib——RET融合阳性非小细胞肺癌的曙光

    Selpercatinib: The Dawn of RET Fusion Positive in Non-Small-Cell Lung Cancer

      摘要
      • HTML全文
      • 参考文献(6)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回